Nuvolase Inc. ’s PinPointe™ FootLaser™ Receives Korean Regulatory Approval

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHICO, Calif.--(BUSINESS WIRE)--NuvoLase Inc. announced today that it received approval from the Korea Food & Drug Administration (KFDA) for its Pinpointe FootLaser .

The PinPointe FootLaser was the first light-based device to receive FDA clearance specific to clearing nails infected by onychomycosis, commonly known as nail fungus. With over 125,000 procedures performed worldwide, the PinPointe FootLaser remains one of the only devices on the market today with documented clinically proven efficacy.

Help employers find you! Check out all the jobs and post your resume.

Back to news